A mastectomy does not significantly lower your body’s estrogen levels. Estrogen is produced primarily by the ovaries in premenopausal women, and by fat tissue distributed throughout the body after menopause. Removing breast tissue takes away a relatively small site of local estrogen activity, but it does not disrupt the hormonal systems that control how much estrogen circulates in your blood. The low-estrogen symptoms many women experience after a mastectomy are almost always caused by other treatments given alongside or after surgery, not by the mastectomy itself.
Where Estrogen Actually Comes From
The ovaries are the primary source of estrogen in premenopausal women. They release estradiol, the most potent form of estrogen, directly into the bloodstream in a cyclical pattern tied to the menstrual cycle. This is the main supply that maintains bone density, regulates body temperature, supports cardiovascular health, and drives reproductive function.
After menopause, when the ovaries wind down production, fat tissue becomes the dominant source of circulating estrogen. The adrenal glands, brain, skin, and pancreas also contribute smaller amounts. Fat tissue throughout the body, not just in the breasts, converts other hormones into estrogen using an enzyme called aromatase. This conversion happens in abdominal fat, thigh fat, and fat deposits elsewhere, meaning the breast is only one of many sites involved.
Breast tissue does produce estrogen locally, and those local concentrations can be biologically meaningful within the breast itself. But this locally made estrogen acts and is metabolized on-site, with limited spillover into the general circulation. Removing the breast eliminates that local production, but it doesn’t meaningfully change the estrogen levels measured in your blood. Your ovaries (if still functioning) or your body-wide fat tissue continue producing estrogen at roughly the same rate.
Why You Might Feel Like Your Estrogen Dropped
Between 65% and 100% of women with breast cancer experience at least one menopause-like symptom during or after treatment. Hot flashes, night sweats, vaginal dryness, mood changes, fatigue, and sleep problems are all common. It’s natural to connect these symptoms to the surgery itself, but the culprits are typically chemotherapy, hormone-blocking medications, or ovarian suppression therapy.
Chemotherapy can damage the ovaries directly, pushing premenopausal women into early menopause. This is called chemotherapy-induced ovarian failure, and it causes a real, measurable drop in estrogen. Unlike the gradual decline of natural menopause, the hormonal shift is abrupt, which often makes symptoms more frequent and more severe. Younger women tend to recover ovarian function more often than women closer to natural menopause age, but the timeline is unpredictable.
Hormone therapy prescribed after surgery for estrogen-receptor-positive breast cancer is another major driver. Tamoxifen blocks estrogen from binding to breast cells, while aromatase inhibitors reduce estrogen production throughout the body by shutting down the conversion that happens in fat tissue. These medications are often taken for five to ten years and can produce persistent low-estrogen symptoms for the entire duration of treatment. The symptoms are a direct, intended effect of the drug, not a consequence of the mastectomy.
Ovarian suppression therapy, sometimes given alongside hormone-blocking drugs in younger women, shuts down ovarian estrogen production with injections. And prophylactic oophorectomy, the surgical removal of the ovaries sometimes recommended for women with BRCA1 or BRCA2 mutations, causes immediate surgical menopause with a sudden and permanent loss of ovarian estrogen. When oophorectomy is performed alongside mastectomy, it’s the ovary removal that causes the hormonal crash.
Mastectomy vs. Oophorectomy
The distinction matters because these two surgeries do fundamentally different things to your hormones. Oophorectomy removes the organs responsible for the vast majority of estrogen production in premenopausal women. It triggers immediate menopause, with estrogen levels plummeting within days. Mastectomy removes tissue that uses estrogen locally but plays no significant role in supplying the rest of the body.
In clinical research on women with BRCA mutations, models account for the hormonal consequences of oophorectomy (sometimes recommending hormone replacement therapy until the age of natural menopause to offset the loss). No such hormonal compensation is built into models for mastectomy alone, because mastectomy doesn’t create a systemic hormone deficit that needs replacing.
What This Means for Hormone-Sensitive Cancer
If your breast cancer is estrogen-receptor-positive, the concern isn’t that your body has too much estrogen in general. It’s that estrogen can fuel the growth of any remaining cancer cells that have receptors for it. Mastectomy removes the tumor and breast tissue, which eliminates the local environment where estrogen was acting on those cells. But because circulating estrogen levels remain the same, your oncologist will typically prescribe systemic hormone therapy to lower estrogen body-wide or block its effects on any microscopic cancer cells that may have spread.
This is why hormone therapy after mastectomy is so common for hormone-receptor-positive cancers. The surgery handles the local disease; the medication handles the hormonal environment. The two work together, but they target different problems.
Sorting Out Your Symptoms
If you’re experiencing hot flashes, joint pain, fatigue, or other symptoms that feel hormone-related after a mastectomy, it helps to identify which treatment is most likely responsible. Women who received chemotherapy in the past 12 months are roughly 2.5 times more likely to report numbness and tingling, for example, which can stem from both the nerve-damaging effects of chemotherapy and hormonal changes. Premenopausal women are more likely to report severe fatigue after chemotherapy and during the early years of hormone therapy.
Your menopausal status before treatment, your age, the specific drugs you received, and how recently you finished chemotherapy all influence which symptoms show up and how intense they are. A blood test measuring estradiol and follicle-stimulating hormone (FSH) can clarify whether your ovaries are still functioning or whether you’ve entered menopause, which helps pin down whether your symptoms are hormonal, treatment-related, or both.